Shree Ganesh (SGRL) | Stock Overview & Key Data
Shree Ganesh Performance Comparison
Stock Range
Today's Range
Low: ₹535.00
High: ₹550.00
on August 8, 2025
52 Week Range
Low: ₹525.50
High: ₹950.00
on August 7, 2025
on February 5, 2025
All-Time High: ₹950.05 on July 22, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR6.9B
EPS
17.02
P/E Ratio (TTM)
31.71
Forward P/E
N/A
P/B Ratio
4.78
PEG Ratio
-1.62
Div. Yield
N/A
ROE
15.89%
Beta
0.247
Debt to Equity
26.44
Financial Highlights
Profitability
Gross Margin
76.08%
Operating Margin
19.77%
Profit Margin
20.16%
Returns and Earnings
Return on Assets (TTM)
12.02%
Return on Equity (TTM)
15.89%
EBITDA
INR429.4M
Net Income (TTM)
INR218.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR84.51
Quarterly Revenue Growth (YoY)
-0.50%
Quarterly Earnings Growth (YoY)
-25.90%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Shree Ganesh SGRL | 6.93B Small-cap | -6.27% | -7.83% | -24.44% | -33.11% | -17.95% | -35.65% | 133.51% | 548.04% |
| Sun Pharmaceutical SUNPHARMA | 3.84T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Sun Pharma Advanced SPARC | 46.34B Small-cap | -4.83% | -8.86% | 0.02% | -8.70% | -28.94% | -34.79% | -34.46% | -20.13% |
| Aarti Drugs AARTIDRUGS | 44.83B Small-cap | 0.47% | 3.52% | 17.71% | 21.40% | 7.96% | -1.73% | 18.09% | -4.28% |
| Sequent Scientific SEQUENT | 42.04B Small-cap | -0.34% | -9.41% | 8.30% | 7.32% | -9.00% | 22.29% | 57.12% | 26.68% |
Ownership & Short Interest
Insider Ownership
75.75%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
6K
Average 90-Day Volume
8K
Shree Ganesh Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Shree Ganesh would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SGRL's 52-week high and low?
- In the last 52 weeks, Shree Ganesh reached a high of ₹950.00 (on February 5, 2025) and a low of ₹525.50 (on August 7, 2025).
- What is the market cap and P/E ratio for SGRL?
- Curious about Shree Ganesh's size and valuation? Its market capitalization stands at 6.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is 31.71, and the forward P/E (looking ahead) is N/A.
- Does SGRL pay dividends? If so, what's the yield?
- As for dividends, Shree Ganesh isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Shree Ganesh's main competitors or similar companies to consider before investing?
When looking at Shree Ganesh, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.84T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Sun Pharma Advanced
SPARC46.34B Healthcare Drug Manufacturers - Specialty & Generic -34.79% -34.46% Aarti Drugs
AARTIDRUGS44.83B Healthcare Drug Manufacturers - Specialty & Generic -1.73% 18.09% Sequent Scientific
SEQUENT42.04B Healthcare Drug Manufacturers - Specialty & Generic 22.29% 57.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Shree Ganesh Remedies Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Shree Ganesh's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.89%, the Debt to Equity ratio from the most recent quarter is 26.44, and its Gross Profit Margin stands at 76.08%.
- What is the recent revenue and earnings growth for SGRL?
- Looking at Shree Ganesh's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.50%, and quarterly earnings saw a YoY growth of -25.90%.
- How much of SGRL stock is held by insiders and institutions?
- Wondering who owns Shree Ganesh stock? Company insiders (like executives and directors) hold about 75.75% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.